In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
395 News Items found
Scientific image showing spindle-shaped and round dormant metastatic cancer cells
Dormant Cancer Cells Change Shape To Survive Immune System Attack

New MSK research reveals how dormant metastatic cancer cells protect themselves from the immune system by changing their shape.
DNA molecules wrapped around histones
Feature
The Future of Cancer Research: Five Reasons for Optimism

Discover some of the most exciting research that Memorial Sloan Kettering scientists are pursuing in the fight against cancer.
Dr. Sohrab Shah
Fighting Cancer With Computers, Math, and Artificial Intelligence

MSK Drs. Larry Norton, Dana Pe’er, and Sohrab Shah know cancer research isn’t all beakers and test tubes — computers and algorithms are some of the most powerful tools in cancer research.
Medical oncologist Emily Feld
Q&A
Metastatic and Metastasized Cancers: Answers to 7 Common Questions

In this Q&A, medical oncologist Emily Feld talks about how metastatic cancer is diagnosed and treated at MSK.
MSK radiation oncologist Kathryn Beal
In the Clinic
Treating Brain Cancer with Radiation Plus Immunotherapy: A Successful Synergy?

MSK’s Kathryn Beal presents new findings on combining radiation with immunotherapy for brain cancer.
Alicia Kalogeropoulos with her husband, Alex, at the beach.
Feature
Top Cancer Treatment Advances at MSK in 2023

Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2023. Read about some of the most important developments over the past year.
bowl of edamame
Does Eating Soy Increase Estrogen and Cause Breast Cancer?

Learn whether eating soy products causes cancer.
Dr. Shanu Modi speaks with a patient
In the Clinic
FDA Approves Trastuzumab Deruxtecan (T-DXd) for Early-Stage HER2-Positive Breast Cancer

The FDA has approved trastuzumab deruxtecan (T-DXd, Enhertu) for treating early-stage, HER2-positive breast cancer based in part on clinical research led by MSK breast medical oncologist Shanu Modi, MD.
Sir Murray Brennan and Bob Li wearing white coats and posing for a photo outside
The War on Cancer Must Be Global: MSK Experts Promote More Collaboration at Forbes China Summit

Learn about how MSK staff members recently participated in the 2021 Forbes China Healthcare Summit and spoke about how the war on cancer must be fought internationally with teams collaborating across political boundaries.
3D illustration of a heart
Q&A
Breast Cancer Treatment and the Risk of Heart Disease: What to Know

The American Heart Association recently issued a statement about the risk of cardiovascular disease for women with breast cancer.